- Home
- FTEK vs PLRX Comparison
FTEK vs PLRX Comparison
Compare FTEK & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTEK
- PLRX
- Stock Information
- Founded
- FTEK 1987
- PLRX 2015
- Country
- FTEK United States
- PLRX United States
- Employees
- FTEK N/A
- PLRX N/A
- Industry
- FTEK Pollution Control Equipment
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- FTEK Industrials
- PLRX Health Care
- Exchange
- FTEK Nasdaq
- PLRX Nasdaq
- Market Cap
- FTEK 79.1M
- PLRX 89.0M
- IPO Year
- FTEK N/A
- PLRX 2020
- Fundamental
- Price
- FTEK $3.55
- PLRX $1.53
- Analyst Decision
- FTEK Strong Buy
- PLRX Hold
- Analyst Count
- FTEK 1
- PLRX 10
- Target Price
- FTEK $4.00
- PLRX $3.93
- AVG Volume (30 Days)
- FTEK 291.9K
- PLRX 725.5K
- Earning Date
- FTEK 11-05-2025
- PLRX 11-06-2025
- Dividend Yield
- FTEK N/A
- PLRX N/A
- EPS Growth
- FTEK N/A
- PLRX N/A
- EPS
- FTEK N/A
- PLRX N/A
- Revenue
- FTEK $25,074,000.00
- PLRX N/A
- Revenue This Year
- FTEK $17.16
- PLRX N/A
- Revenue Next Year
- FTEK $15.00
- PLRX N/A
- P/E Ratio
- FTEK N/A
- PLRX N/A
- Revenue Growth
- FTEK N/A
- PLRX N/A
- 52 Week Low
- FTEK $0.87
- PLRX $1.10
- 52 Week High
- FTEK $3.65
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- FTEK 69.37
- PLRX 44.68
- Support Level
- FTEK $2.71
- PLRX $1.66
- Resistance Level
- FTEK $3.65
- PLRX $1.85
- Average True Range (ATR)
- FTEK 0.24
- PLRX 0.13
- MACD
- FTEK 0.07
- PLRX -0.02
- Stochastic Oscillator
- FTEK 89.36
- PLRX 12.20
About FTEK Fuel Tech Inc.
Fuel Tech Inc is an technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.